Indication

Streptococcus empyema

*Streptococcus* empyema is an advanced, purulent pleural space infection caused by bacteria of the genus *Streptococcus*, most commonly *Streptococcus pneumoniae*, the *Streptococcus anginosus* group, or *Streptococcus pyogenes*. Read more about Streptococcus empyema

15 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Streptococcus empyema therapies.

Showing 10–15 of 15 drugs

Filter & compare in the drug finder →Opens the drug finder with Streptococcus empyema preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Streptococcus empyema.

*Streptococcus* empyema is an advanced, purulent pleural space infection caused by bacteria of the genus *Streptococcus*, most commonly *Streptococcus pneumoniae*, the *Streptococcus anginosus* group, or *Streptococcus pyogenes*.

Affecting the respiratory system in both pediatric and adult populations, it typically arises as a complicated parapneumonic effusion secondary to bacterial pneumonia or contiguous aspiration-related infection.

Pathophysiologically, the condition is characterized by bacterial invasion across the visceral pleura, intense neutrophilic inflammation, acidic pleural fluid with elevated lactate dehydrogenase, and dense fibrin deposition that leads to loculation and pus accumulation within the pleural cavity.

Personalize your experience

Follow Streptococcus empyema and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it